thetaOwl

PFE

Pfizer, Inc.Close $25.66EOD only
Max Pain
$25.50
Next expiry May 22, 2026
Expected Move
±$0.51
2.0% from close
Price Gap
-0.16
Distance to max pain
IV Rank
0
Low premium
P/C OI
0.95
Balanced positioning
Consensus
4/4
Partial coverage
Published snapshot: May 19, 2026 close
End-of-day snapshot

This page reflects PFE options positioning from the latest published market-close snapshot. Intraday price and contract changes are not displayed.

Published Snapshot
May 19, 2026 close
PFE Earnings Report
Analysis based on market close March 31, 2026

Consensus-supported lens with chain history and key metrics in the rail.

Earnings Verdict

Earnings expected ~May 5, 2026 (~35 days). IV for the 5/08 expiration is elevated (33.2% vs ~26-29% elsewhere), suggesting a crush play is viable. Historical pattern shows consistent EPS beats and positive price reactions, favoring a directional call bias. However, the low absolute expected move (±$2.26, 8.1%) and pinning gamma regime limit explosive potential.

Confidence:
6.5 / 10
base 5; +1 strong historical beat rate; +0.5 elevated IV for 5/08; -0.5 low absolute EM; -0.5 gamma regime pinning
Most important: IV term structure shows a clear kink at the 5/08 (38d) expiration, confirming earnings are priced for that cycle. Historical EPS beat rate is 100% with an average surprise of +$0.31.
📅Earnings date estimated as ~May 5, 2026, priced into the 5/08 options expiration (38 days out).
📊Historical EPS beat rate is 100% with an average surprise of +$0.31 over last 4 quarters.
⚖️Spot ($28.08) is above all near-term max pain levels ($26-$27.50), supporting a bullish pinning bias.

Regime Classification

Vol Regime
Normal (IV 29%)
Gamma Regime
Pinning (GEX +$222.9M — mean-reverting)
Flow Regime
Bullish (net prem +$6.3M, P/C 0.40)
Spot vs MP
Above max pain by 6.0% (spot $28.08 vs MP $26)
Gamma flip: ~$20.00Gamma flip estimated ~$20 based on heavy $20 Put OI. Below $20, dealers would amplify moves.

Earnings Overview

Next earnings: 2026-05-05 (35 days)explicit (EPS estimate provided for date)

Expected moves:

  • 5/08 (38d): ±$2.26 (8.1%)
  • 5/15 (45d): ±$2.29 (8.2%)

IV Setup

Term structure: Pronounced kink at 5/08 expiration (33.2% IV) vs 26-29% for surrounding expirations. IV drops sharply to 29.1% for 5/15.

Crush estimate: ~4-7 vol pts, back to ~26-27% range post-earnings.

Skew: Flow is heavily bullish (P/C 0.40), but OI is more balanced (P/C 0.82). Unusual activity shows both OTM call and put buying.

Historical Context

Beat rate: 100% (4/4 quarters)

Avg move vs expected: Cannot calculate exact % move vs EM from data, but all 4 recent quarters showed positive EPS surprises averaging +$0.31.

Directional bias: Strongly bullish based on consecutive positive EPS surprises and current bullish flow.

Key Levels

1$20 (Gamma Flip / Major Put OI)
2$28 (Spot / Major Call OI)
3$30 (Major Call OI Wall)
4EM 5/08: $25.5 - $30.5

Flow Highlights

Heavy net premium into $28C (+$1.54M), $27C (+$1.20M), and $30C (+$875K).

Strong institutional bullish flow into near-term and earnings-expiry calls.

Unusual $30.50C 4/17 bought (966 vol vs 203 OI, 4.8x).

Earnings-adjacent upside bet, targeting a breakout above $30.50.

Strategies

Short Strangle (IV Crush + Range)
Sell $25.50 Put / Sell $30.50 Call 5/08
Credit: $0.60-$0.80
Max loss: Unlimited (defined by width - credit)
Max gain: $0.70
BE: $24.80 / $31.20
Trigger: Enter 5-7 days before estimated earnings date (late April).
Capitalizes on elevated IV at the 5/08 expiry. Strikes are placed just outside the expected move ($25.5-$30.5) to provide a buffer. Historical tendency to beat supports a range-bound or upward move.
Outperforms: Stock stays within $25.50-$30.50 range through May expiration; IV crushes from 33%.
Underperforms: Stock gaps beyond breakevens on earnings, especially below $25 given heavy put OI.
Bull Call Spread (Directional + Defined Risk)
Buy $28 Call / Sell $30 Call 5/08
Max loss: Debit paid
Max gain: $2.00
BE: $28 + debit paid (est. ~$28.60)
Trigger: On any pullback to $27.50-$28.00 support ahead of earnings.
Leverages strong historical beat rate and bullish flow. Defined risk play targeting the major OI wall at $30. Cheaper than a long call due to selling the $30 call against heavy OI resistance.
Outperforms: Stock rallies post-earnings, approaching or exceeding $30.
Underperforms: Stock fails to rally or sells off post-earnings.
Long Straddle (Volatility + Big Move)
Buy $28 Straddle 5/08
Max loss: Debit paid (est. ~$2.30)
Max gain: Unlimited
BE: $25.70 / $30.30
Trigger: Enter only if IV for 5/08 remains below 35% and stock is not pinned at $28.
Despite historical beats, the stock has been range-bound ($26-$30 MP). This is a lower-probability bet that guidance or other news triggers a larger-than-expected move, breaching the heavy OI at $20/$30.
Outperforms: Actual move exceeds 8.1% EM (breakeven move is ~8.2%).
Underperforms: Stock pins near $28 and IV crushes post-earnings.

Risk Assessment

!Gap Risk: Expected move is a modest ±8.1%. Major break below $25 or above $30.50 could accelerate due to gamma/dealer hedging.
!IV Crush: ~4-7 vol point crush expected post-earnings. Long premium strategies need a significant directional move to overcome crush.
!Liquidity: Good (2M+ OI), but volume is moderate. Stick to major strike levels ($25, $27, $28, $30) for best fills.
!Sizing: Use reduced size due to pinning gamma regime which can suppress realized volatility near key strikes.

What to Watch

?IV trajectory for the 5/08 expiration into late April — a further spike improves short premium entry.
?Spot price action relative to max pain ($26) and the $28 level — a hold above $28 confirms bullish flow conviction.
?Any unusual OTM put flow to counter the dominant bullish call flow, signaling hidden downside risk.
How to Use These Reports
This earnings reflects the market close on March 31, 2026.
What the reports do

Each report translates the same market-close options snapshot into a specific lens such as directional bias, premium-selling posture, flow quality, or earnings setup.

How traders use them

Reports are most useful for narrowing the playbook, surfacing entry and risk context, and deciding which raw data page to inspect next.

What to remember

These are interpretation layers, not execution guarantees. Validate the setup against chain liquidity, expected move, and exposure before sizing risk.

If the report conviction and the raw data disagree, slow down and resolve the mismatch before sizing risk.